323 related articles for article (PubMed ID: 21289285)
1. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.
Shatanawi A; Romero MJ; Iddings JA; Chandra S; Umapathy NS; Verin AD; Caldwell RB; Caldwell RW
Am J Physiol Cell Physiol; 2011 May; 300(5):C1181-92. PubMed ID: 21289285
[TBL] [Abstract][Full Text] [Related]
2. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway.
Shatanawi A; Lemtalsi T; Yao L; Patel C; Caldwell RB; Caldwell RW
Eur J Pharmacol; 2015 Jan; 746():106-14. PubMed ID: 25446432
[TBL] [Abstract][Full Text] [Related]
4. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
Toque HA; Romero MJ; Tostes RC; Shatanawi A; Chandra S; Carneiro ZN; Inscho EW; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2010 Dec; 7(12):3857-67. PubMed ID: 20807329
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.
Yao L; Chandra S; Toque HA; Bhatta A; Rojas M; Caldwell RB; Caldwell RW
Cardiovasc Res; 2013 Mar; 97(3):509-19. PubMed ID: 23250919
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.
Chandra S; Fulton DJR; Caldwell RB; Caldwell RW; Toque HA
Eur J Pharmacol; 2019 Feb; 844():26-37. PubMed ID: 30502342
[TBL] [Abstract][Full Text] [Related]
7. Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells.
Subramanian V; Golledge J; Heywood EB; Bruemmer D; Daugherty A
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):397-405. PubMed ID: 22095985
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway.
Yang D; Liu J; Tian C; Zeng Y; Zheng YH; Fang Q; Li HH
Acta Pharmacol Sin; 2010 Oct; 31(10):1401-6. PubMed ID: 20644550
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
Kang YS; Park YG; Kim BK; Han SY; Jee YH; Han KH; Lee MH; Song HK; Cha DR; Kang SW; Han DS
J Mol Endocrinol; 2006 Apr; 36(2):377-88. PubMed ID: 16595708
[TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.
Priviero FB; Jin LM; Ying Z; Teixeira CE; Webb RC
J Pharmacol Exp Ther; 2010 Apr; 333(1):184-92. PubMed ID: 20093396
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
Hu C; Dandapat A; Mehta JL
Hypertension; 2007 Nov; 50(5):952-7. PubMed ID: 17893372
[TBL] [Abstract][Full Text] [Related]
13. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.
Ming XF; Barandier C; Viswambharan H; Kwak BR; Mach F; Mazzolai L; Hayoz D; Ruffieux J; Rusconi S; Montani JP; Yang Z
Circulation; 2004 Dec; 110(24):3708-14. PubMed ID: 15569838
[TBL] [Abstract][Full Text] [Related]
14. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.
Chandra S; Romero MJ; Shatanawi A; Alkilany AM; Caldwell RB; Caldwell RW
Br J Pharmacol; 2012 Jan; 165(2):506-19. PubMed ID: 21740411
[TBL] [Abstract][Full Text] [Related]
15. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα
He Z; Yang Y; Wen Z; Chen C; Xu X; Zhu Y; Wang Y; Wang DW
J Lipid Res; 2017 Jul; 58(7):1338-1353. PubMed ID: 28554983
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
Montezano AC; Burger D; Paravicini TM; Chignalia AZ; Yusuf H; Almasri M; He Y; Callera GE; He G; Krause KH; Lambeth D; Quinn MT; Touyz RM
Circ Res; 2010 Apr; 106(8):1363-73. PubMed ID: 20339118
[TBL] [Abstract][Full Text] [Related]
18. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
Zhang Z; Wang M; Xue SJ; Liu DH; Tang YB
Cardiovasc Drugs Ther; 2012 Feb; 26(1):31-40. PubMed ID: 22083280
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
